Niva Bupa shares jump 15%, scale to 4-month high on beat Q4 results

Q4 boost: Niva Bupa climbs 15% as profit and premium growth beat estimates

Shares of Niva Bupa Health Insurance rose 15 percent to touch a four-month high of Rs 93 per share on May 8 after the company posted a better-than-expected performance for the March quarter of FY25.

Over the past one month, the stock of this private health insurer has gained over 24 percent, in comparison to an 8 percent rise in the benchmark Nifty 50 index.

Catch all the market action on our LIVE blog

The company reported a 31.2 percent year-on-year (YoY) increase in net profit, at Rs 206 crore for the quarter ended March 31, 2025, compared to Rs 157 crore in the same quarter last year. Gross Written Premium (GWP) for Q4FY25 stood at Rs 2,395 crore, registering a 36 percent YoY rise.

Niva Bupa also expanded its retail health market share from 9.1 percent in FY24 to 9.4 percent in FY25, further cementing its position among the leading players in the Indian health insurance sector.

For the road ahead, the company said it intends to invest in building a strong and distinctive brand, accelerating digital transformation, and widening its distribution footprint to strengthen its market position and provide enhanced healthcare protection to millions of Indians.

“Our focus remains on innovating for the customer, simplifying the claims process, and strengthening our digital backbone to drive further efficiencies and scalability,” the company said in its Q4 earnings filing.

Motilal Oswal initiated coverage on the stock with a ‘Buy’ rating and a target price of Rs 100, citing robust growth potential.

Earlier, ICICI Securities also started coverage with a ‘Buy’ rating and a target price of Rs 90. The brokerage pointed out that Niva Bupa stands to benefit from India’s still underpenetrated health insurance market, with its retail market share rising from 4 percent in FY19 to 9.4 percent in the first eleven months of FY25.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.